Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions (BE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04938856
Recruitment Status : Completed
First Posted : June 24, 2021
Last Update Posted : June 24, 2021
Sponsor:
Collaborator:
The Searle Company LTD., Pakistan.
Information provided by (Responsible Party):
Dr. Muhammad Raza Shah, University of Karachi

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 24, 2020
Actual Study Completion Date : October 25, 2020